Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...

Days after her latest “vetting” attempt was overruled at the Department of Health and Human Services, the MAGA provocateur appeared to begin her revenge tour.

Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...

Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...

Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...

By Betsy Klein, Meg Tirrell, Sarah Owermohle, Adam Cancryn, CNN (CNN) — Dr. Vinay Prasad, a controversial critic of the US Food and Drug ...

Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...

The public deserves to the full story about Dr. Vinay Prasad's temporary resignation and how this might impact regulatory decisions moving forward.

One analyst speculated that, going forward, Prasad may be less “heavy-handed” in reviewing rare disease therapies given the ...

Vinay Prasad is returning to his role at the U.S. Food and Drug Administration, a little more than a week after he had left the agency as director of the Center for Biologics Evaluation and Research.